Future Aspects on Inflammatory Bowel Disease

References

• Gilat T, Hacohen D, Lilos P, Langman M JS. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol 1987; 22: 1009–24
   PubMed Web of Science ®Google Scholar
• Persson P G, Leijonmarck C E, Bernell O, Hellers G, Ahlbom A. Risk indicators for inflammatory bowel disease. Int J Epidemiol 1993; 22: 268–72
   PubMed Web of Science ®Google Scholar
• Gent A E, Hellier M D, Grace R H, Swarbrick E T, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994; 343: 766–7
   PubMed Web of Science ®Google Scholar
• Ekbom A, Adami H O, Helmick C G, Jonzon A, Zack M M. Perinatal risk factors for inflammatory bowel disease: a case-control study. Am J Epidemiol 1990; 132: 1111–19
   PubMed Web of Science ®Google Scholar
• Whorwell P J, Holdstock G, Whorwell G M, Wright R. Bottle feeding, early gastroenteritis, and inflammatory bowel disease. Br Med J 1979; 1: 382
   PubMed Web of Science ®Google Scholar
• Wakefield A J, Lewin J, Dhillon A P, Sim R, Pounder R E. Confirmation of persistent measles virus infection of intestinal tissue by immunogold electron microscopy. Gut 1995; 36: 564–9
   PubMed Web of Science ®Google Scholar
• Ekbom A, Wakefield A J, Zack M, Adami H O. The role of perinatal measles infection in the etiology of Crohn's disease: a population-based epidemiological study. Lancet 1994; 344: 508–10
   PubMed Web of Science ®Google Scholar
• Lindberg E, Järnerot G. The incidence of Crohn's disease is not decreasing in Sweden. Scand J Gastroenterol 1991; 26: 495–500
   PubMed Web of Science ®Google Scholar
• Tysk C, Järnerot G. Seasonal variation in exacerbations of ulcerative colitis. Scand J Gastroenterol 1993; 28: 95–6
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, D'Haens G, Hiele M, Geboes K, Vantrappen G. Appendectomy protects against ulcerative colitis. Gastroenterology 1994; 106: 1251–3
   PubMed Web of Science ®Google Scholar
• Logan R FA, Duggan A E, Usmani J, Neal K R. Appendectomy, tonsillectomy and risk of inflammatory bowel disease [abstract]. Gastroenterology 1995; 108: A865
   PubMed Web of Science ®Google Scholar
• Groisman G M, George J, Harpaz N. Ulcerative appendicitis in universal and nonuniversal ulcerative colitis. Modern Pathol 1994; 7: 322–5
   PubMed Web of Science ®Google Scholar
• Andresen A FR. Gastrointestinal manifestations of food allergy. Med J Rec Suppl 1925; 122: 271–5
   Google Scholar
• Panza E, Franceshi S, La Vecchia S, Parrazzini F, Petrillo M, Decarli A, Bianchi Porro G. Dietary factors in the aetiology of inflammatory bowel disease. Ital J Gastroenterol 1987; 19: 205–9
   Google Scholar
• Persson P G, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology 1992; 3: 47–52
   PubMed Web of Science ®Google Scholar
• Lindberg E, Tysk C, Andersson K, Järnerot G. Smoking and inflammatory bowel disease. A case control study. Gut 1988; 29: 352–7
   PubMed Web of Science ®Google Scholar
• Lindberg E, Järnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992; 33: 779–82
   PubMed Web of Science ®Google Scholar
• Cottone M, Rosseli M, Orlando A, Oliva L, Puelo A, Cappelo M, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994; 106: 643–8
   PubMed Web of Science ®Google Scholar
• Vessey M, Jewell D, Smith A, Yeates D, McPherson K. Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of child-bearing age. Br Med J 1986; 292: 1101–3
   PubMed Web of Science ®Google Scholar
• Gaffney P R, Cuimin T D, Gaffney A, Hogan J, Hayes D P, Annis P. Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol 1995; 90: 220–3
   PubMed Web of Science ®Google Scholar
• Lorenz R, Born P, Olbert P, Classen M. Factor XIII substitution in ulcerative colitis [letter]. Lancet 1995; 345: 449–50
   PubMed Web of Science ®Google Scholar
• Thompson N P, Wakefield A J, Pounder R E. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 1995; 108: 1011–5
   PubMed Web of Science ®Google Scholar
• Monsøn U, Iselius L, Johansson C, Hellers G. Evidence for a major additive gene in ulcerative colitis. Clin Genet 1989; 36: 411–4
   PubMed Web of Science ®Google Scholar
• Orrholm M, Iselius L, Sörensen T IA, Munkholm P, Langholz E, Binder V. Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. Br Med J 1993; 306: 20–4
   PubMedGoogle Scholar
• Tysk C, Lindberg E, Järnerot G, Flodørus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988; 29: 990–6
   PubMed Web of Science ®Google Scholar
• Shanahan F, Duerr R H, Rotter J I, Yang H, Sutherland L R, McElree C, et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992; 103: 456–61
   PubMed Web of Science ®Google Scholar
• Yang P, Järnerot G, Danielsson D, Tysk C, Lindberg E. PANCA in monozygotic twins with inflammatory bowel disease. Gut 1995; 36: 887–90
   PubMed Web of Science ®Google Scholar
• Tsai H H, Dwarakanath A D, Hart C A, Milton J D, Rhodes J M. Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment. Gut 1995; 36: 570–6
   PubMed Web of Science ®Google Scholar
• Kruis W, Schötz E, Stolte M, Fixa B, Kralove H, Fric P, Judmaier G. Double-blind comparison between mesalamine (Salofalk) and a preparation of viable E. coli Nissle (Mutafior) for maintenance therapy of ulcerative colitis [abstract]. Gastroenterology 1917–1995; 108: A853
   Google Scholar
• Srivastava E D, Record C O, Green J, Allison M C, Williams G T, Dettmar P W, et al. Effect of Carbopol 934P on the clinical course of active ulcerative colitis [abstract]. Gastroenterology 1995; 108: A899
   Web of Science ®Google Scholar
• Helgeland L, Tysk C, Järnerot G, Kett K, Lindberg E, Danielsson D, et al. IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease. Gut 1992; 33: 1358–64
   PubMed Web of Science ®Google Scholar
• Harper P H, Lee E CG, Kettlewell M GW, Bennett B K, Jewell D P. Role of the faecal stream in the maintenance of Crohn's disease. Gut 1985; 26: 279–84
   PubMed Web of Science ®Google Scholar
• Hollander D, Vadheim C M, Brettholz E, Petersen G, Delahunty T, Rotter J. Increased intestinal permeability in patients with Crohn's disease and their relatives. Ann Intern Med 1986; 105: 883–5
   PubMed Web of Science ®Google Scholar
• Munkholm P, Langholz E, Hollander D, Thornberg K, Orholm M, Katz K D, Binder V. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first-degree relatives. Gut 1994; 35: 68–72
   PubMed Web of Science ®Google Scholar
• Lindberg E, Söderholm J D, Olaison G, Tysk C, Järnerot G. Intestinal permeability to polyethylene glycols in monozygotic twins with Crohn's disease. Scand J Gastroenterol 1995; 30: 780–83
   PubMed Web of Science ®Google Scholar
• Stronkhorst A, Tytgat G NJ, van Deventer S JH. CD4 antibody treatment in Crohn's disease. Scand J Gastroenterol 1992; 27 Suppl 194: 61–5
   Web of Science ®Google Scholar
• Van Dullemen H M, van Deventer S JH, Hommes D W, Bejl H A, Jansen J, Tytgat G NJ, Woody J. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995; 109: 129–35
   PubMed Web of Science ®Google Scholar